TotalMarketCap

Dr Reddys Laboratories

RDYNYSE IndiaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$12.132 B

$14.54 -1.59%

Close of 6 Nov 2026

As of 6 Nov 2026, Dr Reddys Laboratories (RDY) has a market capitalization of $12.1B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

834,656,970

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #27Jazz PharmaceuticalsJAZZ$14.6B
  2. #28BridgeBio PharmaBBIO$14.5B
  3. #29Dr Reddys LaboratoriesRDY$12.1B
  4. #30Elanco Animal HealthELAN$11.8B
  5. #31Summit TherapeuticsSMMT$11.5B

What if Dr Reddys Laboratories were worth as much as…

Open the what-if tool →

Gold $28.2T

$33,830.51

Per share 2,328× higher

Bitcoin $1.53T

$1,830.51

Per share 126× higher

Apple $5.02T

$6,009.39

Per share 413× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Dr Reddys Laboratories are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.